The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
The Federal Trade Commission on Friday filed a lawsuit over insulin prices against the three largest pharmaceutical middlemen ...
The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...
The Federal Trade Commission has sued America’s largest prescription-drug ... The competition regulator’s complaint names CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth Group’s Optum, ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
Regulator claims companies rigged pharmaceutical supply chain competition in their favor, forced patients to pay more for ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
Insulin, used by millions of Americans, has taken center stage in the high-stakes battle over health care costs. Though ...
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback